Legend Biotech Corporation
LEGN
Cena:
$ 29.37
+1.38 (4.93%)
Valuace
100
Růst
60
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
LEGEND BIOTECH HIGHLIGHTS NEW CARVYKTI® DATA IN MULTIPLE MYELOMA AND FIRST-IN-HUMAN RESULTS FROM NOVEL CAR-T PLATFORM IN NON-HODGKIN LYMPHOMA AT ASH 2025
06-12-2025
SOMERSET, N.J., DEC. 06, 2025 (GLOBE NEWSWIRE) -- LEGEND BIOTECH CORPORATION (NASDAQ: LEGN) (LEGEND ...
Více zde
LEGEND BIOTECH CELEBRATES OFFICIAL OPENING OF NEW STATE-OF-THE-ART CELL THERAPY RESEARCH AND DEVELOPMENT FACILITY IN PHILADELPHIA
13-11-2025
31,000-SQUARE-FOOT SITE EXPANDS LEGEND'S U.S. R&D FOOTPRINT AND STRENGTHENS ITS POSITION AS A GLOBAL...
Více zde
LEGEND BIOTECH ANNOUNCES 10 PRESENTATIONS AT THE 67TH AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING
03-11-2025
TWO ORAL AND SEVEN POSTER PRESENTATIONS FURTHER SUPPORT THE CARVYKTI® RESEARCH IN MULTIPLE MYELOMA ...
Více zde
LEGEND BIOTECH TO HOST INVESTOR CONFERENCE CALL ON THIRD QUARTER 2025 RESULTS
29-10-2025
SOMERSET, N.J., OCT. 29, 2025 (GLOBE NEWSWIRE) -- LEGEND BIOTECH CORPORATION (NASDAQ: LEGN) (LEGEND ...
Více zde
LEGEND BIOTECH APPOINTS CARLOS SANTOS AS CHIEF FINANCIAL OFFICER
18-08-2025
SOMERSET, N.J., AUG. 18, 2025 (GLOBE NEWSWIRE) -- LEGEND BIOTECH CORPORATION (NASDAQ: LEGN) (LEGEND ...
Více zde
LEGEND BIOTECH REPORTS SECOND QUARTER 2025 RESULTS AND RECENT HIGHLIGHTS
11-08-2025
SOMERSET, N.J., AUG. 11, 2025 (GLOBE NEWSWIRE) -- LEGEND BIOTECH CORPORATION (NASDAQ: LEGN) (LEGEND ...
Více zde
LEGEND BIOTECH CORPORATION INVESTIGATION: LEVI & KORSINSKY INVESTIGATES POTENTIAL SECURITIES FRAUD BY LEGEND BIOTECH CORPORATION (LEGN)
11-06-2025
NEW YORK, NY / ACCESS NEWSWIRE / JUNE 11, 2025 / LEVI & KORSINSKY NOTIFIES INVESTORS THAT IT HAS COM...
Více zde
LEGN STOCK ALERT: LEVI & KORSINSKY NOTIFIES LEGEND BIOTECH CORPORATION INVESTORS OF AN ONGOING INVESTIGATION
10-06-2025
NEW YORK, NY / ACCESS NEWSWIRE / JUNE 10, 2025 / LEVI & KORSINSKY NOTIFIES INVESTORS THAT IT HAS COM...
Více zde
SHAREHOLDERS THAT LOST MONEY ON LEGEND BIOTECH CORPORATION (LEGN) SHOULD CONTACT LEVI & KORSINSKY ABOUT SECURITIES FRAUD INVESTIGATION - LEGN
09-06-2025
NEW YORK, NY / ACCESS NEWSWIRE / JUNE 9, 2025 / LEVI & KORSINSKY NOTIFIES INVESTORS THAT IT HAS COMM...
Více zde
LEVI & KORSINSKY ANNOUNCES AN INVESTIGATION ON BEHALF OF LEGEND BIOTECH CORPORATION (LEGN) SHAREHOLDERS WHO MAY HAVE BEEN AFFECTED BY FRAUD
06-06-2025
NEW YORK, NY / ACCESS NEWSWIRE / JUNE 6, 2025 / LEVI & KORSINSKY NOTIFIES INVESTORS THAT IT HAS COMM...
Více zde
LEGN ALERT- LEVI & KORSINSKY HAS COMMENCED AN INVESTIGATION ON BEHALF OF LEGEND BIOTECH CORPORATION SHAREHOLDERS WHO LOST MONEY
05-06-2025
NEW YORK, NY / ACCESS NEWSWIRE / JUNE 5, 2025 / LEVI & KORSINSKY NOTIFIES INVESTORS THAT IT HAS COMM...
Více zde
LEGN ALERT- LEVI & KORSINSKY HAS COMMENCED AN INVESTIGATION ON BEHALF OF LEGEND BIOTECH CORPORATION SHAREHOLDERS WHO LOST MONEY
04-06-2025
NEW YORK, NY / ACCESS NEWSWIRE / JUNE 4, 2025 / LEVI & KORSINSKY NOTIFIES INVESTORS THAT IT HAS COMM...
Více zde
LEGEND BIOTECH UNVEILS GROUNDBREAKING 5-YEAR SURVIVAL DATA FOR CARVYKTI® IN MULTIPLE MYELOMA AT 2025 ASCO ANNUAL MEETING
03-06-2025
SOMERSET, N.J., JUNE 03, 2025 (GLOBE NEWSWIRE) -- LEGEND BIOTECH CORPORATION (NASDAQ: LEGN) (LEGEND ...
Více zde
LEGN ACTIVE INVESTIGATION: CONTACT LEVI & KORSINSKY IF YOU LOST MONEY ON YOUR LEGEND BIOTECH CORPORATION INVESTMENT
29-05-2025
NEW YORK, NY / ACCESS NEWSWIRE / MAY 29, 2025 / LEVI & KORSINSKY NOTIFIES INVESTORS THAT IT HAS COMM...
Více zde
LEGEND BIOTECH CORPORATION INVESTIGATED BY SHAREHOLDER RIGHTS ADVOCATES - INVESTORS SHOULD CONTACT LEVI & KORSINSKY REGARDING POTENTIAL SECURITIES LAW VIOLATIONS - LEGN
28-05-2025
NEW YORK, NY / ACCESS NEWSWIRE / MAY 28, 2025 / LEVI & KORSINSKY NOTIFIES INVESTORS THAT IT HAS COMM...
Více zde
LEGEND BIOTECH CORPORATION (LEGN) SHAREHOLDERS MAY HAVE BEEN AFFECTED BY FRAUD - LEVI & KORSINSKY INVESTIGATES
27-05-2025
NEW YORK, NY / ACCESS NEWSWIRE / MAY 27, 2025 / LEVI & KORSINSKY NOTIFIES INVESTORS THAT IT HAS COMM...
Více zde
SHAREHOLDER RIGHTS ADVOCATES AT LEVI & KORSINSKY INVESTIGATE LEGEND BIOTECH CORPORATION (LEGN) REGARDING POSSIBLE SECURITIES FRAUD VIOLATIONS
23-05-2025
NEW YORK, NY / ACCESS NEWSWIRE / MAY 23, 2025 / LEVI & KORSINSKY NOTIFIES INVESTORS THAT IT HAS COMM...
Více zde
LEGEND BIOTECH ANNOUNCES NEW ONCOLOGIC & HEMATOLOGIC THERAPEUTIC DEVELOPMENTS AT ASCO, EHA, AND ASGCT
22-05-2025
SOMERSET, N.J., MAY 22, 2025 (GLOBE NEWSWIRE) -- LEGEND BIOTECH CORPORATION (NASDAQ: LEGN) (LEGEND B...
Více zde
LEGN ALERT- LEVI & KORSINSKY HAS COMMENCED AN INVESTIGATION ON BEHALF OF LEGEND BIOTECH CORPORATION SHAREHOLDERS WHO LOST MONEY
22-05-2025
NEW YORK, NY / ACCESS NEWSWIRE / MAY 22, 2025 / LEVI & KORSINSKY NOTIFIES INVESTORS THAT IT HAS COMM...
Více zde
LEGN ALERT: LEVI & KORSINSKY REMINDS INVESTORS OF AN INVESTIGATION INVOLVING POSSIBLE SECURITIES FRAUD VIOLATIONS BY LEGEND BIOTECH CORPORATION
21-05-2025
NEW YORK, NY / ACCESS NEWSWIRE / MAY 21, 2025 / LEVI & KORSINSKY NOTIFIES INVESTORS THAT IT HAS COMM...
Více zde
LEGEND BIOTECH CORPORATION INVESTIGATED REGARDING POTENTIAL SECURITIES LAW VIOLATIONS - CONTACT LEVI & KORSINSKY FOR DETAILS - LEGN
20-05-2025
NEW YORK, NY / ACCESS NEWSWIRE / MAY 20, 2025 / LEVI & KORSINSKY NOTIFIES INVESTORS THAT IT HAS COMM...
Více zde
LEGEND BIOTECH CORPORATION INVESTIGATED BY SHAREHOLDER RIGHTS ADVOCATES - INVESTORS SHOULD CONTACT LEVI & KORSINSKY REGARDING POTENTIAL SECURITIES LAW VIOLATIONS - LEGN
19-05-2025
NEW YORK, NY / ACCESS NEWSWIRE / MAY 19, 2025 / LEVI & KORSINSKY NOTIFIES INVESTORS THAT IT HAS COMM...
Více zde
LEGN ALERT: LEVI & KORSINSKY INVESTIGATES LEGEND BIOTECH CORPORATION FOR POSSIBLE SECURITIES FRAUD VIOLATIONS
15-05-2025
NEW YORK, NY / ACCESS NEWSWIRE / MAY 15, 2025 / LEVI & KORSINSKY NOTIFIES INVESTORS THAT IT HAS COMM...
Více zde
LEGEND BIOTECH REPORTS FIRST QUARTER 2025 RESULTS AND RECENT HIGHLIGHTS
13-05-2025
SOMERSET, N.J., MAY 13, 2025 (GLOBE NEWSWIRE) -- LEGEND BIOTECH CORPORATION (NASDAQ: LEGN) (LEGEND B...
Více zde
LEGEND BIOTECH REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS AND RECENT HIGHLIGHTS
11-03-2025
SOMERSET, N.J., MARCH 11, 2025 (GLOBE NEWSWIRE) -- LEGEND BIOTECH CORPORATION (NASDAQ: LEGN) (LEGEND...
Více zde
LEGEND BIOTECH TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
19-12-2024
SOMERSET, N.J., DEC. 19, 2024 (GLOBE NEWSWIRE) -- LEGEND BIOTECH CORPORATION (NASDAQ: LEGN) (LEGEND ...
Více zde
CARVYKTI® SIGNIFICANTLY IMPROVED MINIMAL RESIDUAL DISEASE NEGATIVITY COMPARED TO STANDARD OF CARE FOR PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
09-12-2024
SOMERSET, N.J., DEC. 09, 2024 (GLOBE NEWSWIRE) -- LEGEND BIOTECH CORPORATION (NASDAQ: LEGN) (LEGEND ...
Více zde
LEGEND BIOTECH TO HOST INVESTOR EVENT DURING THE 66TH AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING AND EXPOSITION
07-11-2024
SOMERSET, N.J., NOV. 07, 2024 (GLOBE NEWSWIRE) -- LEGEND BIOTECH CORPORATION (NASDAQ: LEGN) (LEGEND ...
Více zde
LEGEND BIOTECH TO UNVEIL MINIMAL RESIDUAL DISEASE DATA FROM LANDMARK CARTITUDE-4 TRIAL IN MULTIPLE MYELOMA
05-11-2024
NEW DATA WILL SHOWCASE SIGNIFICANTLY INCREASED AND SUSTAINED MINIMAL RESIDUAL DISEASE (MRD) NEGATIVI...
Více zde
LEGEND BIOTECH APPOINTS ALAN BASH AS PRESIDENT OF CARVYKTI®
04-11-2024
NEWLY CREATED POSITION TO LEAD EFFORTS FOCUSED ON CONTINUED GROWTH AND SALES NEWLY CREATED POSITION ...
Více zde
Dokumenty nejsou k dispozici
